An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Ji, Changwei ^a   Liu, Zhao ^a   Chen, Huimei ^b   Guo, Hongqian ^a   Liu, Changjian ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DNA POLYMORPHISM; DOMINANT GENE; ETHNIC DIFFERENCE; GENE; GENETIC ANALYSIS; GENETIC MODEL; HARDY WEINBERG DISTRIBUTION LAW; HOGG1 GENE; HOMOZYGOTE; HUMAN; MEDLINE; RECESSIVE GENE; SMOKING;

ALLELES; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84864453950     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-335     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006, 56(2):106-130. 10.3322/canjclin.56.2.106, 16514137.
2. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med 2001, 249(6):477-493. 10.1046/j.1365-2796.2001.00839.x, 11422654.
3. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, Miller AB. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 1989, 44(4):622-628. 10.1002/ijc.2910440411, 2793235.
4. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA 2011, 306(7):737-745. 10.1001/jama.2011.1142, 3441175, 21846855.
5. Vineis P, Talaska G, Malaveille C, Bartsch H, Martone T, Sithisarankul P, Strickland P. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer 1996, 65(3):314-316. 10.1002/(SICI)1097-0215(19960126)65:3<314::AID-IJC6>3.0.CO;2-2, 8575850.
6. Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, Itoh H, Kasai H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 1997, 18(9):1763-1766. 10.1093/carcin/18.9.1763, 9328173.
7. Wiencke JK. DNA adduct burden and tobacco carcinogenesis. Oncogene 2002, 21(48):7376-7391. 10.1038/sj.onc.1205799, 12379880.
8. Sangrajrang S, Schmezer P, Burkholder I, Waas P, Boffetta P, Brennan P, Bartsch H, Wiangnon S, Popanda O. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat 2008, 111(2):279-288. 10.1007/s10549-007-9773-7, 17922186.
9. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 2000, 377(1):1-8. 10.1006/abbi.2000.1773, 10775435.
10. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11(12):1513-1530.
11. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, Nohmi T, Kasai H, Yokota J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16(25):3219-3225. 10.1038/sj.onc.1201872, 9681819.
12. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005, 42(3):127-141. 10.1002/mc.20067, 15584022.
13. Choi JY, Hamajima N, Tajima K, Yoo KY, Yoon KS, Park SK, Kim SU, Lee KM, Noh DY, Ahn SH, et al. hOGG1 Ser326Cys polymorphism and breast cancer risk among Asian women. Breast Cancer Res Treat 2003, 79(1):59-62. 10.1023/A:1023305826726, 12779082.
14. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ, Baba S, Ohno Y, Gao C, et al. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1999, 8(8):669-674.
15. Wikman H, Risch A, Klimek F, Schmezer P, Spiegelhalder B, Dienemann H, Kayser K, Schulz V, Drings P, Bartsch H. hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population. Int J Cancer 2000, 88(6):932-937. 10.1002/1097-0215(20001215)88:6<932::AID-IJC15>3.0.CO;2-P, 11093817.
16. Ito H, Hamajima N, Takezaki T, Matsuo K, Tajima K, Hatooka S, Mitsudomi T, Suyama M, Sato S, Ueda R. A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol 2002, 12(3):258-265. 10.2188/jea.12.258, 12164330.
17. Arizono K, Osada Y, Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol 2008, 38(3):186-191. 10.1093/jjco/hym176, 18272472.
18. Gangwar R, Ahirwar D, Mandhani A, Mittal RD. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?. Mutat Res 2009, 680(1-2):56-63.
19. Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 2005, 65(1):70-75. 10.1016/j.urology.2004.08.005, 15667866.
20. Figueroa JD, Malats N, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Tardon A, Serra C, et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 2007, 121(2):233-242. 10.1007/s00439-006-0294-y, 17203305.
21. Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2007, 16(1):84-91. 10.1158/1055-9965.EPI-06-0712, 17220334.
22. Narter KF, Ergen A, Agachan B, Gormus U, Timirci O, Isbir T. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res 2009, 29(4):1389-1393.
23. Karahalil B, Kocabas NA, Ozcelik T. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res 2006, 26(6C):4955-4958.
24. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 2007, 67(15):7540-7545. 10.1158/0008-5472.CAN-07-0048, 17671226.
25. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 2005, 28(2):123-137. 10.1002/gepi.20048, 15593093.
26. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558. 10.1002/sim.1186, 12111919.
27. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634. 10.1136/bmj.315.7109.629, 2127453, 9310563.
28. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127(9):820-826.
29. Kim EJ, Yan C, Ha YS, Jeong P, Yi Kim I, Moon SK, Choi YH, Kim WJ. Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: A novel approach using peptide nucleic acid-mediated, real-time PCR clamping. Urol Oncol 2010,
30. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, Zhang Q, Millikan RE, Lerner S, Dinney CP, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006, 78(3):464-479. 10.1086/500848, 1380289, 16465622.
31. Mittal RD, Mandal RK, Gangwar R. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population. Mech Ageing Dev 2011, 133(4):127-132.
32. de Boer JG. Polymorphisms in DNA repair and environmental interactions. Mutat Res 2002, 509(1-2):201-210.
33. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000, 92(11):874-897. 10.1093/jnci/92.11.874, 10841823.
34. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001, 29(3):306-309. 10.1038/ng749, 11600885.
35. Munafo M. Replication validity of genetic association studies of smoking behavior: what can meta-analytic techniques offer?. Nicotine Tob Res 2004, 6(2):381-382. 10.1080/14622200410001676369, 15203812.
36. Jiang X, Castelao JE, Yuan JM, Stern MC, Conti DV, Cortessis VK, Pike MC, Gago-Dominguez M. Cigarette smoking and subtypes of bladder cancer. Int J Cancer 2012, 130(4):896-901. 10.1002/ijc.26068, 21412765.
37. Lee AJ, Hodges NJ, Chipman JK. Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7,8-dihydro-2'-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol Biomarkers Prev 2005, 14(2):497-505. 10.1158/1055-9965.EPI-04-0295, 15734978.